欢迎访问《茶叶科学》,今天是

茶叶科学 ›› 2011, Vol. 31 ›› Issue (1): 22-26.doi: 10.13305/j.cnki.jts.2011.01.004

• • 上一篇    下一篇

茶多酚片治疗慢性肾小球肾炎的临床观察

王岳飞1, 施小云1, 徐平1, 王关乔2, 吴正启3, 杨贤强1   

  1. 1. 浙江大学茶学系,浙江 杭州 310029;
    2. 浙江萧山第一人民医院,浙江 杭州 311200;
    3. 湖北省中医研究院,湖北 武汉 430065
  • 收稿日期:2010-04-01 修回日期:2010-08-02 出版日期:2011-02-15 发布日期:2019-09-06
  • 作者简介:王岳飞(1968— ),男,浙江天台人,博士,主要从事茶叶生物化学与茶终端产品研究开发,E-mail: zdcy@zju.edu.cn

Clinical Observation of Tea Polyphenol Tablet on Chronic Glomerulonephritis

WANG Yue-fei1, SHI Xiao-yun1, XU Ping1, WANG Guan-qiao2, WU Zheng-qi3, YANG Xian-qiang1   

  1. 1. Department of Tea Science, Zhejiang University, Hangzhou 310029, China;
    2. The First People’s Hospital of Xiaoshan, Hangzhou 311200, China;
    3. Hubei Chinese medicine Institute, Wuhan 430065, China
  • Received:2010-04-01 Revised:2010-08-02 Online:2011-02-15 Published:2019-09-06

摘要: 按照多中心临床试验的原则评价了茶多酚片治疗慢性肾小球肾炎(肺肾气虚症)的有效性和安全性,采用多中心、分层区组随机、双盲双模拟、阳性药物(肾炎四味片)平行对照,观察病例240例,治疗组和对照组各120例,观察周期为8周。治疗8周后,茶多酚片组的疾病疗效、证候疗效、尿蛋白疗效和尿红蛋白疗效的愈显率分别为:35.0%、38.5%、49.6%和59.7%;同时有效率分别为:71.8%、86.1%、80.0%和72.6%,与对照组(肾炎四味片)组间比较均无统计学差异。实验过程中均未见不良反应及严重不良事件发生,茶多酚片组与肾炎四味片组受试者均评价为安全性1级。结果表明,茶多酚片是治疗慢性肾小球肾炎(肺肾气虚症)安全有效的药物,其疗效不低于肾炎四味片。

关键词: 茶多酚, 肾小球肾炎, 慢性, 临床

Abstract: To evaluate the efficiency and safety of tea polyphenol tablet on chronic glomerulonephritis in clinic, a multi-centre, prospective, double-blind and double-mimicry, positive control (shenyan siwei tablet) trial was conducted, and 240 patients (120 patients of treated group and 120 patients of control group) was observed for 8 weeks. After 8 weeks’ treatment, the efficacy in cured rate of relieving clinical symptoms of patiens, the scores of symptoms efficacy, urinary protein efficacy and urine erythrocyte efficacy were 35.0%, 38.5%, 49.6% and 59.7% respectively in tea polyphenol tablet group, and the total effective rate were 71.8%, 86.1%, 80.0% and 72.6% respectively. It showed no difference comparing with positive control group. No adverse effects appeared during the trial, both tea polyphenol tablet and shenyan siwei tablet were evaluated as first-level safety by the patients of trial group and positive control group. All results suggested that tea polyphenol tablet is an efficient and safe drug in treatment of chronic glomerulonephritis, and its efficacy is not less than shenyan siwei tablet.

Key words: tea polyphenols, glomerulonephritis, chronic, clinical

中图分类号: